Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Carcinoma, Renal Cell 8Urinary Bladder Neoplasms 6Prostatic Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Testicular Neoplasms 4Stomach Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasms 4Triple Negative Breast Neoplasms 3Colonic Neoplasms 3Carcinoma, Transitional Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Osteosarcoma 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2Kidney Neoplasms 2Hematologic Neoplasms 2Familial ependymoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

Etoposide 30Carboplatin 30Cisplatin 23Ifosfamide 22Filgrastim 22Paclitaxel 18Peripheral Blood Stem Cell Transplantation 16Bleomycin 13Cyclophosphamide 11Radiotherapy 8Thiotepa 7Magnetic Resonance Spectroscopy 6Gemcitabine 6pegfilgrastim 5Therapeutics 5Polymerase Chain Reaction 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Flow Cytometry 5Busulfan 5etoposide phosphate 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Dexamethasone 4sargramostim 3Vinblastine 3Taxes 3Surveys and Questionnaires 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Testicular Neoplasms × Oxaliplatin × Genitourinary × Clear all
NCT00104676 2025-02-06

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

UNICANCER

Phase 3 Completed
263 enrolled 10 charts
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT00183820 2017-07-07

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

University of Southern California

Phase 2 Completed
30 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT00957905 2017-03-10

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 7 charts
Genitourinary

Testicular Neoplasms

NCT00091182 2013-06-05

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

National Cancer Institute (NCI)

Phase 2 Completed
180 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Carcinoma, Renal Cell, Colonic Neoplasms, Nasopharyngeal Neoplasms, Neuroblastoma, Rectal Neoplasms, Osteosarcoma, Teratoma, Testicular Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Adrenocortical Carcinoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡